MaaT Pharma Revenue and Competitors
Estimated Revenue & Valuation
- MaaT Pharma's estimated annual revenue is currently $11.2M per year.
- MaaT Pharma's estimated revenue per employee is $140,000
Employee Data
- MaaT Pharma has 80 Employees.
- MaaT Pharma grew their employee count by 7% last year.
MaaT Pharma's People
| Name | Title | Email/Phone |
|---|
MaaT Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15640M | 246141 | N/A | N/A | $109.8B |
What Is MaaT Pharma?
MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome. MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spear-head microbiome treatment integration into clinical practice. Hervé Affagard, CEO & Co-founder
keywords:N/A
N/A
Total Funding
80
Number of Employees
$11.2M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MaaT Pharma News
Published: Apr 21, 2022. On March 28th, 2022, MaaT Pharma announced the launch of a pivotal clinical trial for MaaT013, its microbiome ecosystem therapy,...
MaaT Pharma (EURONEXT: MAAT the Company), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem...
MaaT Pharma, a clinical stage biotechnology company, has established a complete approach to restoring patient-microbiome symbiosis in oncology.
Other Companies in Lyon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.6M | 80 | 48% | N/A |
#2 | N/A | 80 | 38% | N/A |
#3 | $20.3M | 81 | -14% | N/A |
#4 | $11.8M | 84 | 31% | N/A |
#5 | $12.2M | 84 | 4% | N/A |